Navigation Links
Shire Delivers Strong First Quarter Performance and Reiterates its Expectation of Good Full Year Earnings Growth
Date:4/26/2012

roducts for the treatment of rare diseases.

OTHER DEVELOPMENTS

$1,100 million 2.75% Convertible Bonds due 2014 (the "Bonds")

On April 9, 2012 the deadline for bondholders to elect to exercise the option to redeem their Bonds in May 2012 passed. As no elections from bond holders were received by this date the Bonds will become repayable on their maturity in May 2014.

Legal Proceedings

Civil Investigative Demand for ADDERALL XR®, ADDERALL XR Authorized Generics and VYVANSE

  • On April 5, 2012 Shire received a Civil Investigative Demand (“CID”) from the United States Federal Trade Commission (“FTC”) requesting that Shire provide it with certain information regarding the supply and reported shortages of ADDERALL XR and its authorized generics and the marketing and sale of ADDERALL XR, its authorized generics and VYVANSE. Shire believes the CID was triggered by reports of product shortages of ADDERALL XR and the authorized generic products in 2011. Shire is cooperating fully with the FTC. Separately, members of the US congress are reviewing industry wide drug shortages which have been well publicized in the US media and Shire has responded to a specific inquiry relating to ADDERALL XR.

Investigation into DERMAGRAFT

  • Shire understands that the Department of Justice, including the US Attorney's Office for the Middle District of Florida, Tampa Division and the US Attorney's Office for Washington, DC, is conducting civil and criminal investigations into the sales and marketing practices of ABH relating to DERMAGRAFT. Shire is cooperating in these investigations.

ADDITIONAL INFORMATION

The following additional information is included in this press release:

Page Overview of First Quarter 2012 Financial Results 8 Financial Information 12 Non GAAP Reconcilia
'/>"/>

SOURCE Shire plc
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25

Related medicine technology :

1. Shire Strives to Increase Adherence Among Chronic Kidney Disease Stage 5 Patients
2. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
3. Shire to Present Additional Scientific Data on ADHD Treatment Portfolio at American Psychiatric Association Annual Meeting
4. Shires Investigational Nonstimulant ADHD Treatment INTUNIV(TM) (Guanfacine Extended Release) Demonstrated Significant Efficacy in Reducing ADHD Symptoms at All Measured Time Points Up to 24 Hours Postdose
5. Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil
6. Shire to add New Orphan Drug to its HGT Portfolio - EU Launch Imminent
7. Shire Withdraws European Application for DAYTRANA(TM) (Methylphenidate Transdermal System)
8. Shire Announces Study Results of the Effects of INTUNIV(TM) (Guanfacine) Extended Release on Secondary Measures in Children with ADHD and Oppositional Symptoms
9. Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week
10. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
11. Shire Receives Fast Track Designation for velaglucerase alfa for Gaucher Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... -- Research and Markets has announced the ... 2014-2017" report to their offering. ... reimbursement for medical expenses, the Chinese orthopedic instrument market ... a CAGR of 19.2% during 2009-2013. Trauma products, spine ... orthopedic instruments in China , of ...
(Date:8/29/2014)... , August 29, 2014 ... Oil Market by Extraction type (SFE, Cold Pressed, ... Personal Care, Pharmaceutical, Food Supplements, Fragrance, & Others) - ... MarketsandMarkets, defines and segments the Amaranth Seed Oil ... market size in terms of value. The Amaranth ...
(Date:8/29/2014)... , Aug. 29, 2014  United Therapeutics Corporation (NASDAQ: ... District Court for the District of New ... the company,s case against Sandoz, Inc. regarding United Therapeutics, ... Sheridan ruled that U.S. Patent No. 6,765,117 is ... Sandoz from marketing its generic product until the expiration ...
Breaking Medicine Technology:China Orthopedic Instrument Industry Report, 2014-2017 2Amaranth Seed Oil Market worth $700.6 Million by 2019 2Amaranth Seed Oil Market worth $700.6 Million by 2019 3Amaranth Seed Oil Market worth $700.6 Million by 2019 4District Court Decision Received In Remodulin Patent Case 2
... recognized for identifying healthy solutions that empower men and women ... natural supplement which includes an ingredient that clinical tests revealed ... by 98%. Men who take Mdrive daily report ... focus. Mdrive - A synergistic blend ...
... ReportsnReports - U.S. Rehabilitation Technology Market ... This research service covers the following market ... electrotherapy - muscle Stimulators, clinical electrotherapy - ultrasound, ... diathermy, continuous passive motion (CPM) machines, clinical treatment ...
Cached Medicine Technology:DreamBrands New Formula Helps Men Feel Younger and Stronger While Naturally Raising Low-T Without Prescription Drugs 2ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 2ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 3ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 4ReportsnReports Adds Market Research Report on U.S. Rehabilitation Technology Market in its Store 5
(Date:8/29/2014)... 29, 2014 According to the ... accepting applications next month for medical marijuana, regulators, ... accepting marijuana as a legalized medicine. New marijuana ... be permitted to operate in accordance with local ... best suited to handle legal cannabis. , ...
(Date:8/29/2014)... Redwood City, Calif. (PRWEB) August 29, 2014 ... center and customer service solutions, today announced that LiveOps ... the Muscular Dystrophy Association's (MDA) Show of Strength Telethon ... and entertainment event raises money and awareness to support ... muscular dystrophy, an aggressive and sometimes fatal muscle disease. ...
(Date:8/29/2014)... August 29, 2014 Thirteen Novant ... prestigious Great 100 Nurses in North Carolina ... nursing excellence and provides scholarships to nursing students at ... from Novant Health Presbyterian Medical Center are: ... Kelley, Nora King, Lissa Ready, Amber Segerlin, Carmen Smith, ...
(Date:8/29/2014)... By Steven Reinberg ... (HealthDay News) -- The vast majority of American babies ... from serious illnesses, federal health officials said Thursday. ... vaccines that prevent measles, mumps, and rubella (MMR); polio; ... Centers for Disease Control and Prevention. "Nationally, vaccination ...
(Date:8/29/2014)... the research group of Dr. John Lewis at the University ... (London, ON) has confirmed that "invadopodia" play a key role ... Cell Reports , shows preventing these tentacle-like structures from forming ... 2 in 5 Canadians will develop cancer in their lifetime, ... disease. In 2014, it,s estimated that nine Canadians will die ...
Breaking Medicine News(10 mins):Health News:Medical Marijuana Approaches Legalization in Chicago 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 2Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 3Health News:LiveOps Supports Muscular Dystrophy Association Show of Strength Telethon 4Health News:Great 100 Honors 13 Novant Health Nurses 2Health News:Most U.S. Babies Get Their Vaccines: CDC 2Health News:Most U.S. Babies Get Their Vaccines: CDC 3Health News:Preventing cancer from forming 'tentacles' stops dangerous spread 2
... systematic review of size and growth in infancy and later ... the first two years of life, are at increased risk ... ,There is an urgent need to tackle rising levels of ... early in life prevention could begin. This study examines the ...
... no link whatsoever between breast cancer and cholesterol levels and ... the same. ,The details of the study are ... Medicine, one of the JAMA/Archives journals. The article says that ... suggest that the statins may work in conjunction with other ...
... The government is likely to invoke the compulsory licensing ... domestic drug //firms to produce and stockpile Swiss drug ... global threat against the most dreaded avian flu virus. ... CL without receipt of an application from the industry. ...
... lung disease (ILD) comprises a large, heterogeneous group ... restrictive lung disease, and abnormal gas exchange with ... challenges because the differential diagnosis includes more than ... ,Researchers from Texas and Colorado conducted a ...
... International (DSI), is an Indian origin Singapore doctor who ... birth of his daughter Jaspreet 25 years ago who ... by Singh// some 25 years ago, on talking in ... Disability he said he wanted to officially earmark march ...
... proven to be a sensitive screening tool for the ... density// of young women can complicate mammographic interpretation. ... for the detection of breast cancer is high and ... interest in using breast MRI as a screening tool. ...
Cached Medicine News:Health News:A New Diagnostic Approach To Pediatric Interstitial Lung Disease 2Health News:Indian Doctor Wants March 21st To Be Celebrated As World Down Syndrome Day 2Health News:MRI as a diagnostic tool for breast cancer 2
... Activa Parkinson's Control Therapy uses electrical ... some of the most disabling motor ... Control Therapy is a safe and ... Parkinson's patients. Activa Therapy controls rigidity, ...
... It features over 600 TV lines of ... has four color temperature selections, scanning size selection ... control allows the user to easily set up ... settings for brightness, chroma, phase, contrast, volume and ...
Craniosorb Absorbable Fixation System (AFS) is uniquely designed to offer simple and reproducible fixation of the cranial flap and allow for complete absorption of the plating system over time....
PoleStar N-10 is a compact MRI unit that does not require a specially constructed surgery suite. The magnetic field is confined to the volume between the magnet poles and it's immediate neighborhood....
Medicine Products: